key: cord-0932323-oct68t0v
authors: More, Namdev; Ranglani, Deepak; Kharche, Shubham; Choppadandi, Mounika; Ghosh, Sumanta; Vaidya, Sumedh; Kapusetti, Govinda
title: Current challenges in identification of clinical characteristics and detection of COVID-19: A comprehensive review
date: 2021-06-05
journal: nan
DOI: 10.1016/j.measen.2021.100052
sha: 6762e12d560fe71f654082e328f7c241a4dcee8d
doc_id: 932323
cord_uid: oct68t0v

World Health Organization (WHO) declares the COVID-19 outbreak as a pandemic. The newly emerging infection has caused around one million deaths worldwide and still counting. There is no specific treatment for the disease, and it can only contain by breaking the spread. So that early and rapid diagnosis of the infection is the only way to control the outbreak. The COVID-19 virus affects the human respiratory system and subsequently infects other vital organs. In consideration of the diagnosis, the present review focuses on the critical diagnostic approaches for COVID-19, including RT-PCR, Chest-CT scan, some biosensor-based systems, etc. Moreover, this review is a specific bird's eye view on recent developments on the point of care devices and related technologies. Additionally, it presented a small glimpse of the pathophysiology and structural aspects of COVID-19. Therefore, the current review can motivate and help the reader to develop cutting-edge diagnostic technologies for the early and rapid detection of the COVID-19.

The first laboratory corona infection was reported on 1 st December 2019, in Wuhan, China. 45 The corona outbreak initially involved in the local market of Huanan seafood market, with 46 41 cases were reported [1] . An epidemiological alert was issued on 31st December 2019 by 47 global health. So, effective vaccines and therapies must be developed as earliest as possible 69 [4] [5] [6] . 70 Coronavirus has "crown-like" spikes on the surface, and its enveloped with the positively 71 charged single-stranded RNA. It has a size ranging from 60 nm to 140 nm in diameter with 72 spike-like projections on its surface [7] . There are four types of coronaviruses, namely 73 HKU1, NL63, 229E, and OC43, which cause mild respiratory symptoms in humans. About 74 the genomic similarity, the virus differs from its ancestors, such as severe acute respiratory 75 syndrome (SARS) by 79% and Middle East Respiratory Syndrome (MERS) by 50%. The 76 genetic data available on the COVID-19 belongs to the beta-coronavirus genus member, and 77 it can bind to the angiotensin-converting enzyme-2 (ACE-II) receptor in humans epithelial 78 cells [8] . There have been two events in the past two decades wherein crossover of animal 79 beta-corona viruses to humans has caused severe disease. The first such instance was in 

(RTC). The typical structural genome sequence of the coronavirus belongs to the cluster of 119 beta coronaviruses that includes Bat-SARS-like (SL)-ZC45, SARS-CoV, Bat-SL ZXC21, and 120 MERS-CoV. The genome orientation of coronavirus shows 58% identity to non-structural 121 protein-coding region and 43% identity of the structural protein-coding region among 122 different types of coronaviruses, with 54% at the whole genome level, suggesting the non-123 structural proteins are more conserved and the structural proteins have more variety to the 124 suitable fluctuating environment [5, 13] . Fig.1 . depicts the structure of SARS-COV-2. The coronaviruses with α and β are prone to infect mammals, while γ and δ genera can infect 128 birds [1, 14] . The virus enters into a human being by the respiratory tract and reaches the 129 alveoli. The alveoli contain two types of pneumocyte cells viz, type I and type II. Type I 130 pneumocytes are involved in gas exchange, and Type II produces a respiratory surfactant 131 type II pneumocyte cells [16] . The spike part of the virus binds to ACEII present on the 134 surface of type II pneumocytes [4, 17] . After successful receptor binding, protease enzymes 135 like TMPRRS2 and cathepsin present on cell membranes break the S protein and thereby, 136 help the virus to access the cytosol of the host cell. The S-protein contains two subunits as 137 S1 and S2. The S2 subunit results in two site cleavages in which one is important for 138 separating the receptor-binding domain. The other is responsible for exposing fusion peptide 139 that inserts into the membrane of the host cell [18] . This process leads to the formation of 140 antiparallel bundles of six-helix, followed by fusion by mixing viral and cellular membranes. 

Presently there is no specific treatment available in the market for COVID 19. The available 168 treatment is symptomatic [23] . Convalescent plasm therapy is used to decrease the death rate 169 of COVID 19. The plasma obtained from COVID19 recovered patient is called convalescent 170 plasma. This convalescent plasma contains antibodies against the virus [24] . Several and infectious risks [26] .Under the immunological reactions various cross-reactivity has been 184 observed such as anaphylactic/anaphylactoid reactions, mild allergic reactions, haemolysis, 185 and transfusion-related acute lung injury. The physiochemical reactions due to convalescent 186 plasma results fluid overload, citrate toxicity, and chemical toxicity.

Oxygen therapy is majorly used in the treatment intervention of patients with high risk. Table 1 . Primer sequence used for the specific genome of COVID-19 [30] . The CT scan is a medical imaging technique that uses X-rays from different angles aimed 241 towards the patient to produce the cross-sectional (slice) images of the targeted body parts.

These sliced images are called the tomographic images, stacked digitally by using a computer infected patient has many lung oddities, and they mapped using CT. Fig.5 Hence the review is highly beneficial to understand the highly complex characteristics of 407 COVID 19 and it helps in finding a better diagnosis method. 

Clinical features of 442 patients infected with 2019 novel coronavirus in Wuhan

The outbreak of COVID-19: An overview

Di Napoli R (2020) Features, evaluation and 449 treatment coronavirus (COVID-19)

Emerging coronaviruses: genome structure, replication, and 451 pathogenesis

A novel coronavirus outbreak of global health 453 concern

Clinical virology

Epidemiological and clinical aspects of Covid-19; a narrative review

A review of coronavirus disease-2019 (COVID-19)

Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Identification of 465 novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory 466 syndrome coronavirus

Structure 468 of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry

The 471 origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an 472 update on the status

COVID-19: A review on molecular basis, pathogenic mechanisms, 475 therapeutic aspects and future projections

Pathogenesis of COVID-19 from a cell biology perspective

Middle East respiratory syndrome 478 coronavirus: another zoonotic betacoronavirus causing SARS-like disease

Angiotensin-converting enzyme 2 (ACE2) 481 as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Coronaviruses: an overview of their replication and pathogenesis

The epidemiology and pathogenesis of coronavirus disease 486 (COVID-19) outbreak

Review of the clinical characteristics of 488 coronavirus disease 2019 (COVID-19)

Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a 490 narrative review

Treatment of COVID-19: old tricks for new challenges

Convalescent plasma as a potential therapy for COVID-19. The 494

Convalescent plasma therapy and its effects on 496 COVID-19 patient outcomes: a systematic review of current literature

Selvi V (2020) Convalescent Plasma: A Challenging Tool to Treat COVID-19 Patients-A Lesson 498 from the Past and New Perspectives. BioMed research international

Chloroquine and hydroxychloroquine 500 as available weapons to fight COVID-19

Rabaan 504 AA (2020) Complete genome sequence of a 2019 novel coronavirus (SARS-CoV-2) strain isolated in 505 Nepal

Primer design for quantitative real-time PCR for the emerging 507 Coronavirus SARS-CoV-2

Computed tomography and radiation risks: what 509 pediatric health care providers should know

Patients with RT-PCR confirmed COVID-19 and normal chest CT

Epidemiological 513 and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a 514 descriptive study

Chest 516 CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Correlation of chest CT and 522 RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

A 528 patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 529 2003-2004 community outbreak of SARS in Guangzhou, China

Piezoelectric properties of graphene oxide: A first-562 principles computational study

Proliferation of chondrocytes on a 3-D modelled 564 macroporous poly (hydroxyethyl methacrylate)-gelatin cryogel

Incorporating chitin derived 567 glucosamine sulfate into nanofibers via coaxial electrospinning for cartilage regeneration

Advances in 570 porous scaffold Design for Bone and Cartilage Tissue Engineering and regeneration

Osteoblast function on electrically 573 conductive electrospun PLA/MWCNTs nanofibers

Improved piezoelectric performances of highly orientated poly 575 (β-hydroxybutyrate) electrospun nanofiber membrane scaffold blended with multiwalled carbon 576 nanotubes

Evaluation of the effects of 578 hyaluronic acid on poly (3-hydroxybutyrate)/chitosan/carbon nanotubes electrospun scaffold: 579 structure and mechanical properties

Preparation and characterization of graphene 584 oxide/poly (vinyl alcohol) composite nanofibers via electrospinning

Biological evaluation of the effects of Hyaluronic acid 596 on Poly (3-hydroxybutyrate) based Electrospun Nanocomposite scaffolds for cartilage tissue 597 engineering application

Can Graphene-based Materials Play a 607 Role in the Fight against

Rapid 609 Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens 610 Using Field-Effect Transistor-Based Biosensor

Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 613 Detection

Chapter 9 -Molecular techniques for speciation of meat

High throughput screening of seafood for foodborne pathogens

Throughput Screening for Food Safety Assessment

Reverse transcription-loop-mediated isothermal amplification 620 system for the detection of rabies virus

Low clinical performance of the Isopollo COVID-19 623 detection kit (M Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: A call for action against 624 low quality products for developing countries

Selective Naked-Eye Detection of SARS-627

CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles

 Disuses in details about various diagnosis methods of COVID 19

Suggested some potential alternatives for development of rapid and specific sensors/kits